Nowadays, colorectal cancer expressing epidermal growth factor receptor (EGFR), a client protein of HSP90, has been targeted using tyrosine kinase inhibitors and monoclonal antibodies [14]. This evidence concerns the gene EGFR and colorectal cancer.